Daily Newsletter

30 October 2023

Daily Newsletter

30 October 2023

UC San Diego named Tri-City’s health care partner

The collaboration aims to offer affordable and accessible healthcare across various specialties.

October 30 2023

Tri-City Healthcare District has announced a partnership with UC San Diego Health to enhance healthcare services in the US region.

Under a joint powers agreement, UC San Diego Health will provide administrative, clinical, and operational management with guidance from a diverse community board.

The collaboration aims to offer affordable and accessible healthcare across various specialties.

Upon the completion of a final agreement, UC San Diego Health will work alongside Tri-City's staff and providers to expand specialty programmes. These include pregnancy and gynaecology, cancer, cardiovascular, neurosurgical, and behavioural health services.

The alliance also plans to re-establish labour and delivery services in the future.

It will involve the creation of a nine-member community board to advise UC San Diego Health on strategic and operational decisions.

Furthermore, UC San Diego Health aims to enhance cancer care at Tri-City.

The redevelopment plans for Tri-City may cover a range of services.

Among these are an infusion centre, radiation oncology, cancer clinics, clinical trials, genetic counselling, and patient counselling and therapy, providing patients with access to advanced cancer treatments.

The 799-bed UC San Diego Health is an academic health system with multiple primary, same-day, and specialty care clinics in the region.

Currently, it is reinvigorating its medical centre campus, with plans for a new outpatient surgical centre.

UC San Diego Health includes UC San Diego Medical Center, Jacobs Medical Center, Sulpizio Cardiovascular Center, Moores Cancer Center, Shiley Eye Institute, Koman Family Outpatient Pavilion, and Altman Clinical and Translational Research Institute.

Is the healthcare industry ready to fully embrace the benefits of digitalization and AI?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close